ES2034885A1 - Procedimiento para la preparacion de cetoalquilglicerofosfolipidos. - Google Patents

Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.

Info

Publication number
ES2034885A1
ES2034885A1 ES919101611A ES9101611A ES2034885A1 ES 2034885 A1 ES2034885 A1 ES 2034885A1 ES 919101611 A ES919101611 A ES 919101611A ES 9101611 A ES9101611 A ES 9101611A ES 2034885 A1 ES2034885 A1 ES 2034885A1
Authority
ES
Spain
Prior art keywords
group
antitumor
ketoalkylglycerophospholipids
processes
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES919101611A
Other languages
English (en)
Other versions
ES2034885B1 (es
Inventor
Germano Carganico
Casellas David Mauleon
Torro M Desamparados Fos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to ES9101611A priority Critical patent/ES2034885B1/es
Priority to AU22292/92A priority patent/AU2229292A/en
Priority to PCT/EP1992/001502 priority patent/WO1993001196A1/en
Publication of ES2034885A1 publication Critical patent/ES2034885A1/es
Application granted granted Critical
Publication of ES2034885B1 publication Critical patent/ES2034885B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE CETOALQUILGLICERO-FOSFOLIPIDOS. LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO PARA OBTENER NUEVOS CETOALQUILGLICEROFOSFOLIPIDOS REPRESENTADOS POR LA FORMULA I FORMULA DONDE RBS1 REPRESENTA UN GRUPO ALQUILO, UN FENILO, O UN GRUPO FENILALQUILO; N ES UN ENTERO ENTRE 3 Y 18, AMBOS INCLUSIVE; RBS2 ES UN GRUPO ALQUILO DE UNO A 12 ATOMOS DE CARBONO; RBS3 ES HIDROGENO, CARBOXILO, ALCOXICARBONILO, ARILALCOXICARBONILO O ARILOXICARBONILO DE MENOS DE 12 ATOMOS DE CARBONO EN LOS TRES ULTIMOS CASOS; Y RBS4, RBS5 Y RBS6, IGUALES O DIFERENTES ENTRE SI, SON HIDROGENO, UN GRUPO ALQUILO DE 1 A 6 ATOMOS DE CARBONO, O NBS+RBS4RBS5RBS6 REPRESENTA UN GRUPO AMONIO CICLICO. DICHOS COMPUESTOS PUEDEN SER UTILIZADOS COMO ANTITUMORALES, ANTIASMATICOS, ANTITROMBOTICOS, ANTIINFLAMATORIOS, ANTIALERGICOS O EN LA PREVENCION DEL SHOCK ANAFILACTICO. ASIMISMO PUEDEN MANIFESTAR ACCION HIPOTENSORA O ANTIANGINOSA.
ES9101611A 1991-07-10 1991-07-10 Procedimiento para la preparacion de cetoalquilglicerofosfolipidos. Expired - Fee Related ES2034885B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES9101611A ES2034885B1 (es) 1991-07-10 1991-07-10 Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.
AU22292/92A AU2229292A (en) 1991-07-10 1992-07-03 Ketoalkylglycerophospholipids having antitumor and anti-platelet aggregation activities, processes for the preparation thereof and pharmaceutical compositions therefrom
PCT/EP1992/001502 WO1993001196A1 (en) 1991-07-10 1992-07-03 Ketoalkylglycerophospholipids having antitumor and anti-platelet aggregation activities, processes for the preparation thereof and pharmaceutical compositions therefrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9101611A ES2034885B1 (es) 1991-07-10 1991-07-10 Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.

Publications (2)

Publication Number Publication Date
ES2034885A1 true ES2034885A1 (es) 1993-04-01
ES2034885B1 ES2034885B1 (es) 1994-03-01

Family

ID=8272953

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9101611A Expired - Fee Related ES2034885B1 (es) 1991-07-10 1991-07-10 Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.

Country Status (3)

Country Link
AU (1) AU2229292A (es)
ES (1) ES2034885B1 (es)
WO (1) WO1993001196A1 (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619686A1 (de) * 1976-05-04 1977-11-24 Max Planck Gesellschaft Anti-tumormittel
EP0138559A2 (en) * 1983-10-11 1985-04-24 Takeda Chemical Industries, Ltd. Ketoalkylphospholipids and their production and use
ES2019552A6 (es) * 1990-04-11 1991-06-16 Menarini Lab Procedimiento para la preparacion de glicerofosfolipidos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751588B2 (ja) * 1985-07-03 1995-06-05 ハフスルント・ニコメド・フアルマ・アクチエンゲゼルシヤフト グリセロ―３（２）―ホスホ―ｌ―セリン誘導体又はその塩及びこれを含有する薬学的調製物
DE3663522D1 (en) * 1985-11-29 1989-06-29 Takeda Chemical Industries Ltd Phospholipid derivatives, their production and use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2619686A1 (de) * 1976-05-04 1977-11-24 Max Planck Gesellschaft Anti-tumormittel
EP0138559A2 (en) * 1983-10-11 1985-04-24 Takeda Chemical Industries, Ltd. Ketoalkylphospholipids and their production and use
ES2019552A6 (es) * 1990-04-11 1991-06-16 Menarini Lab Procedimiento para la preparacion de glicerofosfolipidos.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BIOCHEM. BIOPHYS. RES. COMMUN.,vol.99, 1981 D.J. Hanahan et al. "Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues", pßg.183-188 *

Also Published As

Publication number Publication date
ES2034885B1 (es) 1994-03-01
WO1993001196A1 (en) 1993-01-21
AU2229292A (en) 1993-02-11

Similar Documents

Publication Publication Date Title
CA2235996A1 (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
GB1461209A (en) Thienyl and thietyl compounds
AU649849B2 (en) New vanadium complexes, process for preparing them and pharmaceutical compositions containing them
HUT59663A (en) Process for producing new d vitamine analogues and pharmaceutical compositions containing them as active components
HUT71482A (en) 4,1-benzoxazepine derivatives, process for preparing them and pharmaceutical compositions containing them
CA2071248A1 (en) Composition containing dioxabicyclo-[3.3.0]octane derivative
AU1085492A (en) New n-myristoyltransferase inhibitors, process for preparing these and pharmaceutical compositions containing them
GB1350420A (en) Alkanedioxy titanium chelates
WO2002007677A3 (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
DK0531091T3 (da) Biologisk nedbrydelig copolyester af 4-hydroxyprolin og farmaceutisk præparat indeholdende samme
ES2034885A1 (es) Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.
TW428020B (en) Liquid crystal compound
EP0721945A4 (en) BENZOLACTAM DERIVATIVES
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
ATE195928T1 (de) Neue flüssigkristalline verbindungen die eine dienylgruppe enthalten und flüssigkristalline zusammensetzungen
MXPA03011075A (es) Composiciones de sales de alcanolamina de alquilfosfato esteres.
ES8701174A1 (es) Un metodo de preparacion de un compuesto de tiadiazina
DE60237323D1 (de) Zusammensetzung enthaltend Ferrocen-Derivate und Treibstoff diese enthaltend
CZ59895A3 (en) 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazol-6-(2h)-ones exhibiting antitumor activity
SI1069132T1 (en) Bicyclic derivatives of amino-pyrazinones, process of preparation and pharmaceutical compositions comprising them
EP1403251A4 (en) BIS (2-aryl-5-pyridyl) DERIVATIVES
ES8705427A1 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-pirimidinil- o n-pirazinil-propilaminas
IL106080A (en) Pharmaceutical compositions containing amidinoalkane-1, 1-bisphosphonic acids and some such novel compounds
MY136142A (en) Novel substituted [1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
NZ505110A (en) Neuroprotective agents

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060711